- Email: [email protected]
KMS installs the UK's largest membrane bioreactor system
NEWS
Editorial Office: Elsevier Ltd The Boulevard, Langford Lane Kidlington, Oxford OX5 1GB, UK Tel: +44 1865 843239 Web: www.membrane-technology.com Editor: Simon Atkinson Tel/Fax: +44 (0)1904 655944 Email: [email protected] Production Support Manager: Lin Lucas Email: [email protected] Editorial advisory board: Dr P Ball (Pall Europe), Dr D Bessarabov (HySA Infrastructure: NWU and CSIR), Prof. M Cheryan (University of Illinois at Urbana-Champaign), Prof. A G Fane (University of New South Wales), Dr A C M Franken (Membrane Application Centre Twente), Prof. E Gobina (Robert Gordon University), Dr A Merry (Aquious–PCI Membranes), Prof. M Nyström (Lappeenranta University of Technology), Dr Anil Pabby, Bhabha Atomic Research Centre, India Dr G K Pearce (Membrane Consultancy Associates), Prof. P H Pfromm (Kansas State University), Dr R W Philpott (Progenta Llp), Prof. R J Wakeman (Loughborough University of Technology), Prof. A Yaroshchuk (Ukrainian Membrane Society) Subscription Information An annual subscription to Membrane Technology includes 12 issues and online access for up to 5 users. Subscriptions run for 12 months, from the date payment is received. More information: www.elsevier.com/journals/institutional/membrane-technology/0958-2118 Permissions may be sought directly from Elsevier Global Rights Department, PO Box 800, Oxford OX5 1DX, UK; phone: +44 1865 843830, fax: +44 1865 853333, email: [email protected]. You may also contact Global Rights directly through Elsevier’s home page (www.elsevier.com), selecting first ‘Support & contact’, then ‘Copyright & permission’. In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: +1 978 750 8400, fax: +1 978 750 4744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London W1P 0LP, UK; phone: +44 (0)20 7631 5555; fax: +44 (0)20 7631 5500. Other countries may have a local reprographic rights agency for payments. Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution. Permission of the Publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the Publisher is required to store or use electronically any material contained in this journal, including any article or part of an article. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the Publisher. Address permissions requests to: Elsevier Science Global Rights Department, at the mail, fax and email addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made.Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
12978 Digitally Produced by Mayfield Press (Oxford) Limited (The content of this newsletter is compiled from a variety of sources, including press releases.)
2
Membrane Technology
KMS installs the UK’s largest membrane bioreactor system
Desalination plant in Peru uses NIROBOX smart packaged systems
K
F
och Membrane Systems Inc (KMS) has upgraded the Woolston Wastewater Treatment Works near Southampton in the UK. The company, which develops and manufactures membranes for filtration applications, says that its membrane bioreactor (MBR) system has increased production capacity without expanding the plant’s footprint. In cooperation with 4Delivery, KMS replaced the facility’s existing conventional activated sludge unit with the PULSION® MBR ultrafiltration membrane system – dramatically improving effluent quality by increasing nutrient removal and achieving nearly 100% bacteria and solids removal. As an added benefit, the plant’s long-standing odour control problem was also eliminated by using this technology. PULSION MBR “pulses” a large bubble through a chambered hollow-fibre bundle, creating a highly efficient piston-like pumping action. Taking advantage of the unique single header and central aeration design of the PURON membrane module design, this approach harnesses aeration energy to improve productivity, reduce energy consumption and provide better solids management, says the company. As the UK’s largest MBR, the system is designed to treat wastewater at an average flow of 19 000 m3 (5 million gallons) per day, with a maximum daily capacity of 42 000 m3 (11 million gallons) a day. In addition, the plant features eight filtration trains, each of which comprises five PULSION membrane modules. With a membrane area of more than 76 000 m2 (818 000 ft2), the system produces permeate that meets strict EU Bathing Water directives. ‘Membrane bioreactor technology is innovative because it uses ultrafiltration and biological treatment,’ explained said Jack Noble, General Manager, Water and Wastewater EMEA, KMS. ‘PULSION MBR technology continues to be at the forefront of this field. In addition to improved effluent quality and increased capacity, this technology significantly reduces operating and life-cycle costs.’ For further information, visit: www.kochmembrane.com
luence Corp Ltd, a provider of water and wastewater treatment systems, has secured a build, own and operate contract with an industrial client in Peru, for a desalination plant, including a ten-year water purchase agreement (WPA). The plant will use Fluence’s NIROBOX™ smart packaged systems. Five NIROBOX SW-XL units are being deployed initially. The plant is ultimately expected to expand to 10 units. The initial plant will be a US$8.4 million investment for Fluence, and is expected to deliver a minimum of 1.1 million m3 (290.6 million gallons) of industrial-grade water per year for the WPA customer. Fluence says that the plant is scheduled to be operational by the end of the second quarter of 2019. The initial WPA alone is expected to generate US$1.7 million in annual revenue for the company. Negotiations for WPAs with additional industrial customers are currently under way, says Fluence. Supplemental WPAs with even more off-takers, if secured, would grow the firm’s client-base and have the potential to increase annual recurring revenues up to a total of US$5.0 million (assuming full plant capacity). Commenting on this project, Henry Charrabé, Managing Director and CEO, Fluence, said: ‘Our smart packaged NIROBOX sea-water system is the perfect modular unit for areas that suffer from fresh-water scarcity. In this instance, we will be able to provide highly sought-after relief for industrial clients in this arid region of Peru.’ For further information, visit: www.fluencecorp.com/nirobox
Aquaporin’s technology demonstrates its ability to remove micro-pollutants
M
embrane technology developed by Aquaporin A/s is being tested to demonstrate its ability to remove
February 2019
Editorial Office: Elsevier Ltd The Boulevard, Langford Lane Kidlington, Oxford OX5 1GB, UK Tel: +44 1865 843239 Web: www.membrane-technology.com Editor: Simon Atkinson Tel/Fax: +44 (0)1904 655944 Email: [email protected] Production Support Manager: Lin Lucas Email: [email protected] Editorial advisory board: Dr P Ball (Pall Europe), Dr D Bessarabov (HySA Infrastructure: NWU and CSIR), Prof. M Cheryan (University of Illinois at Urbana-Champaign), Prof. A G Fane (University of New South Wales), Dr A C M Franken (Membrane Application Centre Twente), Prof. E Gobina (Robert Gordon University), Dr A Merry (Aquious–PCI Membranes), Prof. M Nyström (Lappeenranta University of Technology), Dr Anil Pabby, Bhabha Atomic Research Centre, India Dr G K Pearce (Membrane Consultancy Associates), Prof. P H Pfromm (Kansas State University), Dr R W Philpott (Progenta Llp), Prof. R J Wakeman (Loughborough University of Technology), Prof. A Yaroshchuk (Ukrainian Membrane Society) Subscription Information An annual subscription to Membrane Technology includes 12 issues and online access for up to 5 users. Subscriptions run for 12 months, from the date payment is received. More information: www.elsevier.com/journals/institutional/membrane-technology/0958-2118 Permissions may be sought directly from Elsevier Global Rights Department, PO Box 800, Oxford OX5 1DX, UK; phone: +44 1865 843830, fax: +44 1865 853333, email: [email protected]. You may also contact Global Rights directly through Elsevier’s home page (www.elsevier.com), selecting first ‘Support & contact’, then ‘Copyright & permission’. In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: +1 978 750 8400, fax: +1 978 750 4744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London W1P 0LP, UK; phone: +44 (0)20 7631 5555; fax: +44 (0)20 7631 5500. Other countries may have a local reprographic rights agency for payments. Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution. Permission of the Publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the Publisher is required to store or use electronically any material contained in this journal, including any article or part of an article. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the Publisher. Address permissions requests to: Elsevier Science Global Rights Department, at the mail, fax and email addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made.Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
12978 Digitally Produced by Mayfield Press (Oxford) Limited (The content of this newsletter is compiled from a variety of sources, including press releases.)
2
Membrane Technology
KMS installs the UK’s largest membrane bioreactor system
Desalination plant in Peru uses NIROBOX smart packaged systems
K
F
och Membrane Systems Inc (KMS) has upgraded the Woolston Wastewater Treatment Works near Southampton in the UK. The company, which develops and manufactures membranes for filtration applications, says that its membrane bioreactor (MBR) system has increased production capacity without expanding the plant’s footprint. In cooperation with 4Delivery, KMS replaced the facility’s existing conventional activated sludge unit with the PULSION® MBR ultrafiltration membrane system – dramatically improving effluent quality by increasing nutrient removal and achieving nearly 100% bacteria and solids removal. As an added benefit, the plant’s long-standing odour control problem was also eliminated by using this technology. PULSION MBR “pulses” a large bubble through a chambered hollow-fibre bundle, creating a highly efficient piston-like pumping action. Taking advantage of the unique single header and central aeration design of the PURON membrane module design, this approach harnesses aeration energy to improve productivity, reduce energy consumption and provide better solids management, says the company. As the UK’s largest MBR, the system is designed to treat wastewater at an average flow of 19 000 m3 (5 million gallons) per day, with a maximum daily capacity of 42 000 m3 (11 million gallons) a day. In addition, the plant features eight filtration trains, each of which comprises five PULSION membrane modules. With a membrane area of more than 76 000 m2 (818 000 ft2), the system produces permeate that meets strict EU Bathing Water directives. ‘Membrane bioreactor technology is innovative because it uses ultrafiltration and biological treatment,’ explained said Jack Noble, General Manager, Water and Wastewater EMEA, KMS. ‘PULSION MBR technology continues to be at the forefront of this field. In addition to improved effluent quality and increased capacity, this technology significantly reduces operating and life-cycle costs.’ For further information, visit: www.kochmembrane.com
luence Corp Ltd, a provider of water and wastewater treatment systems, has secured a build, own and operate contract with an industrial client in Peru, for a desalination plant, including a ten-year water purchase agreement (WPA). The plant will use Fluence’s NIROBOX™ smart packaged systems. Five NIROBOX SW-XL units are being deployed initially. The plant is ultimately expected to expand to 10 units. The initial plant will be a US$8.4 million investment for Fluence, and is expected to deliver a minimum of 1.1 million m3 (290.6 million gallons) of industrial-grade water per year for the WPA customer. Fluence says that the plant is scheduled to be operational by the end of the second quarter of 2019. The initial WPA alone is expected to generate US$1.7 million in annual revenue for the company. Negotiations for WPAs with additional industrial customers are currently under way, says Fluence. Supplemental WPAs with even more off-takers, if secured, would grow the firm’s client-base and have the potential to increase annual recurring revenues up to a total of US$5.0 million (assuming full plant capacity). Commenting on this project, Henry Charrabé, Managing Director and CEO, Fluence, said: ‘Our smart packaged NIROBOX sea-water system is the perfect modular unit for areas that suffer from fresh-water scarcity. In this instance, we will be able to provide highly sought-after relief for industrial clients in this arid region of Peru.’ For further information, visit: www.fluencecorp.com/nirobox
Aquaporin’s technology demonstrates its ability to remove micro-pollutants
M
embrane technology developed by Aquaporin A/s is being tested to demonstrate its ability to remove
February 2019